Meet Hummingbird Diagnostics
Take the opportunity to meet us and discuss your requests and projects.
Feel free to contact us if you have any questions or if you would like to arrange a meeting email@example.com
Updates on the latest developments at Hummingbird Diagnostics
Be among the first to get updates on the latest developments at Hummingbird Diagnostics by joining our mailing list for journalists.
Contact Hummingbird Diagnostics: firstname.lastname@example.org
Open to new approaches
Exciting publications of the biomarker field
Learn more about genomic biomarkers and read Hummingbirds latest publications.
Are you a scientist interested in cooperative research and publication projects? Send an email to email@example.com.
Technical Stability and Biological Variability in MicroRNAs from Dried Blood Spots: A Lung Cancer Therapy-Monitoring Showcase
Kahraman M, Laufer T, Backes C, Schrörs H, Fehlmann T, et al.
Clin Chem. 2017
Stimulated by clinical
or industrial need
The case studies provide examples of the scientific challenges faced by our customers, and our solutions to them.
If you would like to know how case studies might benefit your organization, please contact us. Let us develop the optimum solutions for your business.
Genome-Wide Screening for microRNA Biomarkers in Micro-Dissected Tissue Samples
CHALLENGE: Biomarker discovery with low sample inputs from micro-dissected tissue samples
MINIMAL CSF INPUTS FOR REPEATED MIRNA BIOMARKER SAMPLING IN RAT
CHALLENGE: Process establishment for repeated sampling with minimal sample inputs from rat and human CSF samples
Clinical Trial Retrospective MiRNA-Profiling
CHALLENGE: High Quality RNA extraction from Plasma samples, clinical trial compliance, high-throughput fast turn around, appropriate controls for normalization
Consulting for design of multi-center study & genome-wide screening for mirna biomarkers
CHALLENGE: Study consulting & setup of multi-center study
mRNA-profiling for optimization of biotechnological production
CHALLENGE: Identification of production relevant pathway deregulation